Insider Profile
Few, Jason Bradley
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Dec 01, 2025
Most Recent Trade
26
Credibility
Score
55%
Hit Rate
+3.1%
Avg 90d Return
+3.9%
Median 90d Return
20
Evaluated Trades
+15.9%
Best Trade
-4.7%
Worst Trade
Hit rate and returns are based on 20 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Date Company Role Nature Dir. Shares Price Value Score
Dec 01, 2025 $ENB
Enbridge
Plan / DRIP Buy 201 83
Nov 28, 2025 $ENB
Enbridge
Comp. Grant Buy 820 83
Sep 19, 2025 $ENB
Enbridge
Comp. Grant Buy 811 83
Sep 01, 2025 $ENB
Enbridge
Plan / DRIP Buy 190 83
Jun 16, 2025 $ENB
Enbridge
Plan / DRIP Buy 183 83
Jun 16, 2025 $ENB
Enbridge
Plan / DRIP Buy 183 83
Jun 13, 2025 $ENB
Enbridge
Comp. Grant Buy 835 83
Jun 01, 2025 $ENB
Enbridge
Plan / DRIP Buy 183 83
Mar 21, 2025 $ENB
Enbridge
Comp. Grant Buy 924 83
Mar 01, 2025 $ENB
Enbridge
Plan / DRIP Buy 175 83
Jun 14, 2024 $ENB
Enbridge
Comp. Grant Buy 1,039 83
Jun 01, 2024 $ENB
Enbridge
Plan / DRIP Buy 143 83
Mar 08, 2024 $ENB
Enbridge
Comp. Grant Buy 1,082 83
Mar 01, 2024 $ENB
Enbridge
Plan / DRIP Buy 129 83
Jun 02, 2023 $ENB
Enbridge
Comp. Grant Buy 1,017 83
Jun 01, 2023 $ENB
Enbridge
Plan / DRIP Buy 61 83
Mar 10, 2023 $ENB
Enbridge
Comp. Grant Buy 1,002 83
Mar 01, 2023 $ENB
Enbridge
Plan / DRIP Buy 39 83
Dec 02, 2022 $ENB
Enbridge
Comp. Grant Buy 876 83
Dec 01, 2022 $ENB
Enbridge
Plan / DRIP Buy 21 83
Sep 09, 2022 $ENB
Enbridge
Comp. Grant Buy 840 83
Sep 01, 2022 $ENB
Enbridge
Plan / DRIP Buy 8 83
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.